17970635|t|Discontinued drugs in 2006: central and peripheral nervous system drugs.
17970635|a|This perspective describes compounds that target the central and peripheral nervous system, whose development was discontinued in 2006 and which were being developed for the treatment of a range of neurological disorders, including chronic pain, Alzheimer's disease, Parkinson's disease, multiple sclerosis, epilepsy and anxiety. These discontinued candidates are described by disease area, based on information available from the Pharmaprojects database.
17970635	28	71	central and peripheral nervous system drugs	Chemical	-
17970635	271	293	neurological disorders	Disease	MESH:D009461
17970635	305	317	chronic pain	Disease	MESH:D059350
17970635	319	338	Alzheimer's disease	Disease	MESH:D000544
17970635	340	359	Parkinson's disease	Disease	MESH:D010300
17970635	361	379	multiple sclerosis	Disease	MESH:D009103
17970635	381	389	epilepsy	Disease	MESH:D004827
17970635	394	401	anxiety	Disease	MESH:D001007

